PROSTASCAN Trademark

Trademark Overview

On Wednesday, April 5, 2000, a trademark application was filed for PROSTASCAN with the United States Patent and Trademark Office. The USPTO has given the PROSTASCAN trademark a serial number of 76017767. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, February 27, 2005. This trademark is owned by Immunomedics, Inc.. The PROSTASCAN trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic reagent, namely, antibody fragment to be radiolabeled for use in diagnosis and monitoring of prostate cancer
prostascan

General Information

Serial Number76017767
Word MarkPROSTASCAN
Filing DateWednesday, April 5, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, February 27, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 4, 2001

Trademark Statements

Goods and ServicesMedical diagnostic reagent, namely, antibody fragment to be radiolabeled for use in diagnosis and monitoring of prostate cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 5, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunomedics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorris Plains, NJ 07950
Party NameImmunomedics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorris Plains, NJ 07950

Trademark Events

Event DateEvent Description
Friday, May 13, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, May 13, 2005ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 9, 2005ASSIGNED TO EXAMINER
Friday, August 6, 2004EXTENSION 5 GRANTED
Friday, August 6, 2004EXTENSION 5 FILED
Friday, August 6, 2004EXTENSION 4 GRANTED
Monday, August 23, 2004CASE FILE IN TICRS
Thursday, February 26, 2004EXTENSION 4 FILED
Friday, August 6, 2004TEAS EXTENSION RECEIVED
Wednesday, July 28, 2004PETITION TO REVIVE-GRANTED
Thursday, March 18, 2004PETITION TO REVIVE-RECEIVED
Friday, April 23, 2004ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 18, 2004PAPER RECEIVED
Wednesday, March 10, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 17, 2003EXTENSION 3 GRANTED
Thursday, June 26, 2003EXTENSION 3 FILED
Thursday, June 26, 2003PAPER RECEIVED
Tuesday, February 25, 2003EXTENSION 2 GRANTED
Tuesday, February 25, 2003EXTENSION 2 FILED
Tuesday, February 25, 2003PAPER RECEIVED
Tuesday, July 16, 2002EXTENSION 1 GRANTED
Friday, June 21, 2002EXTENSION 1 FILED
Friday, June 21, 2002PAPER RECEIVED
Tuesday, February 26, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2001PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2001NOTICE OF PUBLICATION
Monday, July 30, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 26, 2001EXAMINERS AMENDMENT MAILED
Tuesday, March 13, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2000NON-FINAL ACTION MAILED
Friday, September 8, 2000ASSIGNED TO EXAMINER

Related Keywords

prostascan diagnosis monitoring prostate cancer radiolabeled fragment diagnostic reagent namely antibody